financetom
Market
financetom
/
Market
/
FTSE 100 retreats from record high as tariff worries resurface
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
FTSE 100 retreats from record high as tariff worries resurface
Jul 15, 2025 9:57 AM

*

FTSE 100 down 0.7%; FTSE 250 down 0.2%

*

Experian ( EXPGF ) jumps on revenue growth

*

Barratt Redrow ( BTDPF ) slumps on annual home completion miss

*

Reeves, Bailey to speak at Mansion House dinner

(Updates with market closing prices)

By Ankita Yadav

July 15 (Reuters) - The UK's FTSE 100 retreated from

record highs touched earlier in the session on Tuesday as rising

U.S. inflation raised concerns about the impact of tariffs,

while investors also focused on the Bank of England's monetary

policy path.

The blue-chip FTSE 100 dropped 0.7% to 8,938.32,

having crossed the 9,000 mark for the first time earlier in the

day, while the domestically oriented FTSE 250 index fell

0.2%.

Wall Street indexes came under pressure after data showed

U.S. consumer prices increased by the most in five months in

June amid higher costs for some goods, suggesting tariffs were

starting to have an impact on inflation.

However, British stocks have largely shrugged off concerns

about chaotic U.S. trade policies, with the UK being the first

country to secure a trade deal with the United States.

"The FTSE has been fired up partly by its defensive

nature as more investors appear to be seeking shelter from

potential volatility in the US and the unpredictability of the

Trump administration," said Susannah Streeter, senior investment

and markets analyst at Hargreaves Lansdown.

Bank of England Governor Andrew Bailey will give his

annual "Mansion House" address to London's financial sector

later on Tuesday, along with finance minister Rachel Reeves.

Concerns about the economy have prompted traders to increase

their bets of rate cuts from the BoE this year, with investors

looking for at least two quarter-point rate cuts this year.

Among individual stocks, GSK fell 1.5% after the

U.S. Food and Drug Administration raised safety concerns that

the drugmaker's blood cancer drug Blenrep, when used in

combination with other treatments, may cause eye damage in

patients.

Experian ( EXPGF ) rose 4.3% after the credit data firm

reported 8% organic revenue growth in the first quarter and

reaffirmed its annual forecasts.

Barratt Redrow ( BTDPF ) slumped 8.9% after Britain's largest

homebuilder said home completions missed expectations for fiscal

2025.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved